Published in Circulation on December 01, 1990
Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol (2008) 1.98
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
A novel mouse model of in situ stenting. Cardiovasc Res (2010) 1.51
Prediction of imminent, severe deterioration of children with parallel circulations using real-time processing of physiologic data. J Thorac Cardiovasc Surg (2016) 1.39
The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol (2000) 1.22
Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography. Br Heart J (1992) 1.21
Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res (2010) 1.14
The representative porcine model for human cardiovascular disease. J Biomed Biotechnol (2010) 1.06
Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine. PLoS One (2012) 0.94
Inhibition of allograft inflammatory factor-1 expression reduces development of neointimal hyperplasia and p38 kinase activity. Cardiovasc Res (2008) 0.92
Increased artery wall stress post-stenting leads to greater intimal thickening. Lab Invest (2011) 0.87
Coronary restenosis and gene therapy. Tex Heart Inst J (1994) 0.86
IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation. Am J Pathol (2014) 0.83
EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One (2011) 0.82
Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment. BMC Cardiovasc Disord (2002) 0.80
A novel model of accelerated intimal hyperplasia in the pig iliac artery. Int J Exp Pathol (2011) 0.80
Coronary stenting: why size matters. Heart (2007) 0.79
Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury. Curr Vasc Pharmacol (2009) 0.79
Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings. JAMA Ophthalmol (2013) 0.79
Dihydroaustrasulfone alcohol inhibits PDGF-induced proliferation and migration of human aortic smooth muscle cells through inhibition of the cell cycle. Mar Drugs (2015) 0.78
Inhibition of vascular remodelling in a porcine coronary injury model by herbal extract XS0601. Chin Med (2006) 0.78
Large animal models of cardiovascular disease. Cell Biochem Funct (2016) 0.77
Increasing our IQ of vascular smooth muscle cell migration with IQGAP1. Focus on "IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury". Am J Physiol Cell Physiol (2013) 0.77
Ultrastructural characteristics of cellular reaction after experimentally induced lesions in the arterial vessel. Basic Res Cardiol (1995) 0.77
Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis. Int J Exp Pathol (2001) 0.77
Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study. PLoS One (2016) 0.76
Coronary Injury Score Correlates with Proliferating Cells and Alpha-Smooth Muscle Actin Expression in Stented Porcine Coronary Arteries. PLoS One (2015) 0.76
Vitamin D Supplementation Reduces Intimal Hyperplasia and Restenosis following Coronary Intervention in Atherosclerotic Swine. PLoS One (2016) 0.75
Restenosis following coronary angioplasty: current status. Korean J Intern Med (2001) 0.75
Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells. BMC Complement Altern Med (2016) 0.75
Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries - First Experimental Results in Rabbits at Low Inflation Pressure. Cardiovasc Drugs Ther (2016) 0.75
Granulation encapsulated stent: a new therapeutic approach for vascular implantation. Heart (2006) 0.75
Proliferative response of human and minipig smooth muscle cells after coronary angioplasty to growth factors and platelets. Basic Res Cardiol (1997) 0.75
Modulation by beta-aminopropionitrile of vessel luminal narrowing and structural abnormalities in arterial wall collagen in a rabbit model of conventional balloon angioplasty versus laser balloon angioplasty. J Clin Invest (1994) 0.75
Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. Clin Res Cardiol (2008) 0.75
Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting. J Mater Sci Mater Med (2012) 0.75
Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries. Clin Res Cardiol (2008) 0.75
Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med (1997) 9.36
Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc (1984) 9.00
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation (2000) 5.53
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med (1993) 4.56
Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study. J Am Coll Cardiol (1989) 3.95
Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol (1992) 3.94
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67
Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation (1997) 3.52
Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol (1984) 3.31
Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol (1997) 3.22
The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med (1987) 3.17
Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation (1984) 3.15
Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc (1993) 3.14
Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med (1998) 3.04
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87
Pathology of acute and chronic coronary stenting in humans. Circulation (1999) 2.78
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77
Transesophageal echocardiography: technique, anatomic correlations, implementation, and clinical applications. Mayo Clin Proc (1988) 2.71
Secular trends in coronary atherosclerosis--analysis in patients with valvular regurgitation. N Engl J Med (1996) 2.68
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med (2001) 2.54
Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest (1995) 2.53
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52
Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42
Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation (1997) 2.41
Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol (1987) 2.35
Calcified amorphous tumor of the heart (cardiac CAT). Hum Pathol (1997) 2.27
Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation (2000) 2.26
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15
Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol (1998) 2.12
Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning. N Engl J Med (1999) 2.10
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
Coronary restenosis: prospects for solution and new perspectives from a porcine model. Mayo Clin Proc (1993) 2.06
A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03
Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol (1993) 1.99
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 1.99
Tuberous sclerosis and cardiac rhabdomyoma. Am J Cardiol (1995) 1.99
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation (1994) 1.95
Cor triatriatum dexter: two-dimensional echocardiographic diagnosis. J Am Coll Cardiol (1987) 1.95
Permanent pacemaker infections: characterization and management. Am J Cardiol (1981) 1.95
Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med (2000) 1.94
Clopidogrel versus ticlopidine after intracoronary stent placement. J Am Coll Cardiol (1999) 1.92
Primary cardiac angiosarcoma: a clinicopathologic study of six cases. J Thorac Cardiovasc Surg (1992) 1.91
Management of balloon rupture during rigid stent deployment. Cathet Cardiovasc Diagn (1995) 1.91
Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart (2009) 1.89
Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc (1988) 1.87
Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
Surgical pathology of pure aortic insufficiency: a study of 225 cases. Mayo Clin Proc (1984) 1.85
Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc (1989) 1.82
Validation of TRISS and ASCOT using a non-MTOS trauma registry. J Trauma (1995) 1.82
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol (1992) 1.79
Natriuretic peptide system in human heart failure. Circulation (1993) 1.79
Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol (1985) 1.77
Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc (1999) 1.76
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation (1994) 1.76
Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation (1992) 1.75
Dissecting aortic aneurysm associated with congenital bicuspid aortic valve. Circulation (1978) 1.74
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1990) 1.72
Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J (2001) 1.72
Coronary artery stents. JAMA (2000) 1.70
Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg (1986) 1.68
Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest (1998) 1.68
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg (1996) 1.66
Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.65
Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol (1996) 1.65
Surgical pathology of the pulmonary valve: a study of 116 cases spanning 15 years. Mayo Clin Proc (1989) 1.61
Cardiac papillary fibroelastomas. Two-dimensional echocardiographic recognition. Mayo Clin Proc (1981) 1.61
Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation (1996) 1.59
Mesothelial/monocytic incidental cardiac excrescences: cardiac MICE. Mod Pathol (1994) 1.58
Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc (1985) 1.57
Comorbid conditions and outcomes after percutaneous coronary intervention. Heart (2007) 1.57
Impact of 2-Dimensional echocardiography on the management of distressed newborns in whom cardiac disease is suspected. Am J Cardiol (1983) 1.56
Endothelin in human congestive heart failure. Circulation (1994) 1.56
Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med (1983) 1.56
Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc (1987) 1.55
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation (1995) 1.55
Postinfarction rupture of the left ventricular free wall: clinicopathologic correlates in 100 consecutive autopsy cases. Hum Pathol (1990) 1.55
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation (2001) 1.54
Microscopic pulmonary tumor embolism causing subacute cor pulmonale: a difficult antemortem diagnosis. Mayo Clin Proc (1991) 1.53
Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes. J Am Coll Cardiol (2000) 1.53
Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc (1998) 1.53
Long-term outcome of surgical repair of ruptured sinus of Valsalva aneurysm. Circulation (1994) 1.53
Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol (1990) 1.52
Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Coronary Care Unit and Catheterization Laboratory Groups. Mayo Clin Proc (1994) 1.52